Bayer has entered into an alliance with Impli, tapping into the start-up's implantable hormone-monitoring platform, which has potential in fertility treatment and other indications. Impli's biosensor ...

Bayer announced today full results from the Phase III FIND-CKD trial investigating KERENDIA ® (finerenone) in adults with non-diabetic chronic kidney disease (nd-CKD) who were also receiving ...

Bayer BAYN-0.26%decrease; red down pointing triangle said it agreed to buy Perfuse Therapeutics for up to $2.45 billion, snapping up an eye-drug specialist that is developing a potential glaucoma ...

Bayer has struck a deal to buy Perfuse Therapeutics for $300 million upfront. The buyout, which includes up to $2.15 billion in milestones, will give Bayer control of an eye disease implant that ...

This is the first in a three-part series on Bayer’s crusade for immunity from Roundup-related cancer claims, published in partnership with the Center for Media and Democracy. Read the second and third ...

Oral argument set for Monday in Bayer case seeking to block pesticide lawsuits New federal lobbying declaration records released last night reveal that Bayer ramped up federal lobbying in Q1 2026, ...

Inclusive Capital Partners sold ~8.5 million Bayer shares (~0.9% stake) for about $378–$380 million, after initially marketing the block and triggering a short-lived stock decline. The transaction ...

Bayer executives had warned for years that the company was on the brink of pulling its weedkiller Roundup from the U.S. market. But when Health Secretary Robert F. Kennedy Jr. in May released the ...

With a fresh phase 3 win for Kerendia, Bayer is one step closer to pushing the ascendant drug into a much broader population of patients with chronic kidney disease (CKD). Kerendia, also known as ...

Big German manufacturer has lawyers and lobbyists in and outside Washington, D.C., seeking protections for Roundup weedkiller. Company’s actions are a transparent demonstration of power and influence ...

Bayer is proposing a $7.25 billion plan to settle thousands of lawsuits claiming its Roundup weedkiller caused cancer — a high-stakes effort to cap years of mounting legal exposure that will pressure ...

Bayer said on Tuesday that its Monsanto chemical subsidiary has proposed a $7.25 billion settlement to resolve lawsuits by customers alleging that its Roundup weedkiller product caused non-Hodgkin ...